Member Info for Toukankahmoon

Pedrol

Desperation because of what?

I have merely stated that if the clinical trial results we were told to expect by June had been good enough there would be an imminent deal. And we wouldn’t need this £9M raise.

BV

If the clinical trials were delivering super excellent results then the deal would be on Avacta’s terms. It’s the science that matters - remember.

Whatever you say, for some reason there is no imminent deal. No transformational news - AGAIN

Biggi

But it doesn’t alter the fact that if the clinical trial results were good enough to precipitate a deal with BP, we wouldn’t need this raise would we.

Aldebaran

Such a great company (unlike HEMO), never has a bad news days. All Avacta RNS are to be celebrated.

When the SP rises then whoosh here we go fame and fortune is around the corner. When the SP falls, great buying opportunity fill your boots.

BV

You are confirming what I said - no imminent deal.

Also why does Avacta need to raise cash right now to strengthen its negotiating position if the clinical trials are going so well??

One minute it’s a drug trial to save lives, the next CC is gonna sell out to the highest bidder. Make up your minds.

Oneknows

I certainly didn’t see this raise coming

Look I understand that you’ve got a lot (maybe too much) riding on this, but kicking out like a poor wounded animal is not a good look.

I think we are looking at 12 weeks from FPD to release data. Going by AVA6000 timelines. But CC will know how the first doses are going

Doggy

“We know Touk is not invested”?

Presumably from the same source that gives you all the great information on how well Avacta are doing 🤡

I presume you are being sarcastic

Ok

So you still think that the results are good enough to get the deal??

We’ll soon find out. But if it’s imminent then this £9M raise makes no sense at all.

Avacta continues to kick the can down the road for another 6 months at least. Let’s hope they don’t accidentally kick it into the long grass.

The June announcement of clinical trial results was supposed to enable a deal. If it does then why did we need this £9M raise?

It is clear to me that:

- current clinical results are not as good as expected and certainly not good enough to secure the deal CC wants

- so the money had to come from somewhere

Question is - what is going on with the clinical trials???

So pleased I didn’t fill my boots at 77p like I was encouraged to do 🤡

Yep. No such thing as a bad dilution.

Rampers reflect on how little you know about what is going on🤡

BenH

Don’t make me trawl back through all your posts to list times when you’ve misinterpreted or missed something 🤡

Why don’t you stop being so belligerent you’d have much happier life.

For me I have 20 or more investments in addition to prospective ones. I’ve given up carefully dissecting every morsel from CC because it’s proved a waste of time. I’m sure I’ll notice if Avacta hit £1.

DG

Does it explain why it is a character flaw that is generally displayed in a lot of the rampers posts but others including me have stated on a number of occasions that we wish other investors well with their investment? After all, it makes no difference to to me if BH, CJ62, etc make a fortune. Good luck to them.

Runner

Just the the generally nasty spitefulness of some rampers on here.

PS. Little birdy told me ADCs are far too expensive.

But if you invested £10k wisely 5 years ago you would have a far better return by now

Sadly I haven’t got 14 years. But on the bright side the rest of my investments are rumbling on🤣